These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 604253)

  • 1. Isolation and characterisation of a non-toxinogenic mutant of V. cholerae and possibility of a live oral cholera vaccine.
    Datta A; Sasmal D; Datta GC; Pal SC
    Indian J Med Res; 1977 Jun; 65(6):770-6. PubMed ID: 604253
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of a mutant B subunit in toxigenic Vibrio cholerae diminishes production of active cholera toxin in vivo.
    Silva A; Fando R; Benitez JA
    Curr Microbiol; 1998 Oct; 37(4):231-5. PubMed ID: 9732528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE; Lucas C; Bleakley CR
    Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant derivative of a naturally occurring non-toxinogenic Vibrio cholerae 01 expressing the B subunit of cholera toxin: a potential oral vaccine strain.
    Dasgupta U; Bhadra RK; Panda DK; Deb A; Das J
    Vaccine; 1994 Mar; 12(4):359-64. PubMed ID: 8178559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vibrio eltor strain, serotype Ogawa, the producer of cholera enterotoxin].
    Saiamov RM; Avrorov VP; Khanum'ian TA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):40-2. PubMed ID: 6342310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
    Benítez JA; Silva AJ; Rodríguez BL; Fando R; Campos J; Robert A; García H; García L; Pérez JL; Oliva R; Torres CA; Ledón T
    Arch Med Res; 1996; 27(3):275-83. PubMed ID: 8854382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a detection system for wild-type Vibrio cholerae in genetically modified cholera vaccine.
    Studer E; Candrian U
    Biologicals; 2000 Sep; 28(3):149-54. PubMed ID: 10964441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of toxin biosynthesis by plasmids in Vibrio cholerae.
    Khan AA; Srivastava R; Sinha VB; Srivastava BS
    J Gen Microbiol; 1985 Oct; 131(10):2653-7. PubMed ID: 3934328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cholera toxin in enteric colonization by Vibrio cholerae O1 in rabbits.
    Pierce NF; Kaper JB; Mekalanos JJ; Cray WC
    Infect Immun; 1985 Dec; 50(3):813-6. PubMed ID: 4066032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of antibacterial and antitoxin immunities in experimental cholera.
    Srivastava R; Sinha VB; Srivastava BS
    Indian J Med Res; 1979 Sep; 70():369-73. PubMed ID: 535945
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutralisation of the new cholera toxin by antiserum against crude enterotoxin of cholera toxin gene-positive Vibrio cholerae 01 in rabbit ileal loop model.
    Saha S; Sanyal SC
    Indian J Med Res; 1989 May; 89():117-20. PubMed ID: 2777342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute secretory travellers' diarrhoea caused by Vibrio cholerae non-01 which does not produce cholera-like or heat-stable enterotoxins.
    Bhattacharya SK; Bhattacharya MK; Ramamurthy T; Pal A; Bag PK; Takeda T; Shimada T; Dutta P; Debnath A; Chakraborti S
    J Diarrhoeal Dis Res; 1992 Sep; 10(3):161-3. PubMed ID: 1430972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibility of public health hazards by contamination of toxin producing Vibrio cholerae through fishes reared in sewage fed fishery.
    Saha MK; Dutta P; De SP
    Indian J Public Health; 1999; 43(2):71-2. PubMed ID: 11243070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a live oral cholera vaccine in human volunteers.
    Woodward WE; Gilman RH; Hornick RB; Libonati JP; Cash RA
    Dev Biol Stand; 1976; 33():108-12. PubMed ID: 782960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current developments with cholera vaccines: "Where do we go from here?".
    Finkelstein RA
    Prog Clin Biol Res; 1980; 47():133-42. PubMed ID: 7010372
    [No Abstract]   [Full Text] [Related]  

  • 17. [An avirulent vibrio cholerae strain--producer of the cholera toxin B subunit: obtaining and molecular genetic analysis].
    Smirnova NI; Krepostnova IM; Livanova LF; Zadnova SP; Eremin SA; Il'ina TS
    Mol Gen Mikrobiol Virusol; 2007; (4):7-13. PubMed ID: 18154075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenic potential of vibrio cholerae 01 isolated from the Mapocho river and Aguada ditch].
    Herrera N; Prado V; Mamani N; Martínez J; Ojeda A
    Rev Med Chil; 1993 May; 121(5):483-8. PubMed ID: 8272626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metal ions on the production of vascular permeability factor by 569B strain of Vibrio cholerae.
    Sagar IK; Nagesha CN; Bhat JV
    Indian J Med Res; 1979 Jan; 69():18-25. PubMed ID: 429022
    [No Abstract]   [Full Text] [Related]  

  • 20. Enterotoxin production, DNA repair and alkaline phosphatase of Vibrio cholerae before and after animal passage.
    Roy NK; Das G; Balganesh TS; Dey SN; Ghosh RK; Das J
    J Gen Microbiol; 1982 Sep; 128(9):1927-32. PubMed ID: 7175493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.